Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Про Lite Strategy

Засновано

2018

Спільнота

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Деталі збору коштів

Раунд фінансуванняСумаРас. Ціна
Date
Інвестори
Post-IPO
₴4.12B
--
2025-07-21
--